33 studies found for:    Thimerosal
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults
Condition: Influenza
Interventions: Biological: CSL Trivalent Inactivated Influenza Vaccine - Thimerosal-free;   Biological: CSL Trivalent Inactivated Influenza Vaccine with Thimerosal;   Biological: Placebo with Thimerosal
2 Completed
Has Results
Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations
Condition: Influenza Infection
Interventions: Biological: Thiomersal-free FluAS25 adjuvanted vaccine (GSK576389A);   Biological: Thiomersal reduced FluAS25 adjuvanted vaccine (GSK576389A)
3 Completed Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations
Condition: Dermatitis, Contact
Intervention: Biological: TRUE TEST Skin patch test Bioequivalence
4 Completed Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04
Condition: Influenza
Interventions: Biological: Thiomersal free trivalent influenza split vaccine 2003/2004;   Biological: GlaxoSmithKline Biologicals' Influsplit SSW®/Fluarix™ 2003/2004
5 Completed Mercury Levels in Premature and LBW Infants Receiving Thimerosal-containing Vaccines
Condition: Mercury Levels
Intervention:
6 Completed Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03
Condition: Influenza
Interventions: Biological: Thiomersal free trivalent influenza split vaccine 2002/2003;   Biological: GlaxoSmithKline Biologicals' Influsplit SSW®/Fluarix™ 2002/2003
7 Completed
Has Results
Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup
Condition: Influenza
Interventions: Biological: Cell culture derived seasonal trivalent influenza vaccine (cTIV);   Biological: Influenza virus vaccine (egg-derived seasonal trivalent, thiomersal free; eTIV_a).;   Biological: cTIV or eTIV_a;   Biological: cTIV+PV OR eTIV_a+PV
8 Completed
Has Results
Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs
Condition: Prophylaxis Hepatitis B
Interventions: Biological: Engerix™-B (thiomersal-free) 20µg;   Biological: 10 μg Engerix™-B (preservative-free);   Biological: placebo
9 Completed Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns
Condition: Hepatitis B
Interventions: Biological: HepavaxGene (thiomersal free);   Biological: Engerix B
10 Completed Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine
Condition: Prophylaxis Hepatitis B
Intervention: Biological: Hepatitis B vaccine
11 Completed
Has Results
Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children
Condition: Influenza
Interventions: Biological: Fluarix;   Biological: Fluzone
12 Completed
Has Results
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Condition: Influenza Infection
Interventions: Biological: GSK investigational vaccine GSK1557482A;   Biological: Fluzone®
13 Completed Immunogenicity and Safety of GSK Biologicals' FluLaval® TF
Conditions: Influenza;   Influenza Vaccines
Intervention: Biological: FluLaval® TF
14 Completed
Has Results
Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control
Conditions: Influenza Vaccines;   Influenza Virus
Interventions: Biological: GSK Biologicals' influenza vaccine GSK1557482A;   Biological: Vaxigrip
15 Unknown  Study of Dehydrex in Patients With Corneal Erosion
Conditions: Corneal Diseases;   Recurrence
Intervention: Drug: Dehydrex
16 Recruiting Clinical Trial for the Evaluation of Three Regimens of Influenza Vaccination in Kidney Transplant Recipients
Condition: Human Influenza
Intervention: Biological: Trivalent influenza vaccine (inactivated and fragmented).
17 Completed Protectivity and Safety of DTP/HB/Hib (Bio Farma) Vaccines in Infants, Batch Consistency, Multi Center Trial
Condition: Healthy
Intervention: Biological: DTP/HB/Hib Vaccine
18 Completed
Has Results
A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA
Condition: Influenza
Interventions: Biological: CSL425;   Biological: Placebo
19 Completed Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults
Condition: Influenza
Interventions: Biological: Influenza vaccine (A/H3N2, A/H1N1, and B strains);   Biological: Fluarix
20 Completed
Has Results
A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children
Condition: Influenza Caused by the Novel Influenza A (H1N1) Virus
Intervention: Biological: CSL425

Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results
Indicates status has not been verified in more than two years